Enterprise Financial Services Corp (EFSC)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$322K Sell
2,109
-214
-9% -$32.8K 0.16% 106
2025
Q4
$320K Sell
2,323
-44
-2% -$5.76K 0.16% 104
2025
Q3
$304K Sell
2,367
-62
-3% -$7.57K 0.16% 106
2025
Q2
$294K Buy
2,429
+207
+9% +$23.3K 0.16% 115
2025
Q1
$248K Sell
2,222
-794
-26% -$84.5K 0.15% 125
2024
Q4
$293K Buy
3,016
+160
+6% +$17.1K 0.16% 111
2024
Q3
$328K Sell
2,856
-60
-2% -$6.81K 0.19% 106
2024
Q2
$310K Sell
2,916
-348
-11% -$34.9K 0.19% 108
2024
Q1
$316K Sell
3,264
-52
-2% -$5.33K 0.19% 111
2023
Q4
$335K Buy
3,316
+182
+6% +$17.6K 0.2% 110
2023
Q3
$319K Buy
3,134
+35
+1% +$3.55K 0.22% 97
2023
Q2
$313K Sell
3,099
-75
-2% -$7.5K 0.2% 105
2023
Q1
$292K Buy
3,174
+155
+5% +$13.5K 0.19% 113
2022
Q4
$274K Sell
3,019
-37
-1% -$3.12K 0.19% 115
2022
Q3
$232K Sell
3,056
-58
-2% -$4.81K 0.17% 121
2022
Q2
$263K Buy
3,114
+161
+5% +$14.1K 0.05% 224
2022
Q1
$259K Buy
2,953
+228
+8% +$19.7K 0.04% 241
2021
Q4
$238K Sell
2,725
-513
-16% -$42.6K 0.04% 259
2021
Q3
$265K Buy
3,238
+521
+19% +$46.9K 0.03% 262
2021
Q2
$247K Sell
2,717
-432
-14% -$38.5K 0.04% 202
2021
Q1
$269K Buy
3,149
+97
+3% +$8.71K 0.05% 196
2020
Q4
$288K Sell
3,052
-2
-0.1% -$175 0.05% 181
2020
Q3
$266K Sell
3,054
-279
-8% -$24.2K 0.06% 179
2020
Q2
$291K Buy
3,333
+649
+24% +$56K 0.06% 160
2020
Q1
$221K Sell
2,684
-653
-20% -$58.3K 0.06% 183
2019
Q4
$316K Buy
3,337
+587
+21% +$52.7K 0.07% 169
2019
Q3
$239K Hold
2,750
0.05% 195
2019
Q2
$251K Sell
2,750
-267
-9% -$22.6K 0.05% 196
2019
Q1
$260K Buy
3,017
+138
+5% +$11.1K 0.06% 194
2018
Q4
$221K Hold
2,879
0.14% 116
2018
Q3
$222K Sell
2,879
-172
-6% -$12.7K 0.12% 128
2018
Q2
$207K Sell
3,051
-12
-0.4% -$828 0.11% 134
2018
Q1
$222K Buy
3,063
+185
+6% +$14.1K 0.11% 134
2017
Q4
$217K Hold
2,878
0.11% 136
2017
Q3
$221K Hold
2,878
0.11% 131
2017
Q2
$215K Buy
2,878
+47
+2% +$3.33K 0.11% 139
2017
Q1
$188K Sell
2,831
-197
-7% -$13.1K 0.09% 149
2016
Q4
$198K Buy
3,028
+5
+0.2% +$324 0.1% 142
2016
Q3
$214K Buy
3,023
+68
+2% +$4.96K 0.12% 126
2016
Q2
$218K Sell
2,955
-99
-3% -$6.84K 0.13% 118
2016
Q1
$198K Sell
3,054
-16
-0.5% -$1.09K 0.12% 122
2015
Q4
$237K Buy
3,070
+90
+3% +$7.15K 0.14% 112
2015
Q3
$245K Buy
2,980
+95
+3% +$8.46K 0.16% 110
2015
Q2
$254K Hold
2,885
0.15% 112
2015
Q1
$255K Sell
2,885
-4
-0.1% -$355 0.15% 116
2014
Q4
$240K Sell
2,889
-11
-0.4% -$912 0.15% 119
2014
Q3
$245K Hold
2,900
0.16% 115
2014
Q2
$235K Hold
2,900
0.14% 119
2014
Q1
$221K Hold
2,900
0.14% 118
2013
Q4
$209K Hold
2,900
0.12% 122
2013
Q3
$199K Hold
2,900
0.13% 120
2013
Q2
$184K Buy
+2,900
New +$189K 0.13% 117

Other funds holding NVS

Enterprise Financial Services Corp (EFSC)'s NVS Position: Q1 2026 in Review

Enterprise Financial Services Corp (EFSC) reduced its Novartis (NVS) stake by 9.2% in Q1 2026, selling an estimated $32.8K and leaving 2,109 shares worth $322K. The position accounts for 0.16% of the portfolio, ranked #106.

Enterprise Financial Services Corp (EFSC) first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $335K in Q4 2023. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Enterprise Financial Services Corp (EFSC) held 2,109 shares of Novartis worth $322K as of Q1 2026.
  • Enterprise Financial Services Corp (EFSC) sold 214 Novartis shares in Q1 2026, an estimated $32.8K.
  • Novartis made up 0.16% of Enterprise Financial Services Corp (EFSC)'s portfolio in Q1 2026, its #106 holding.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • Enterprise Financial Services Corp (EFSC)'s Novartis position peaked at $335K in Q4 2023.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2026, filed 5 May 2026.